Therapeutic Advances in Gastrointestinal Endoscopy · Published 2026-06-01 · DOI 10.1177/26317745261458987
Jad AbiMansour, Bret T. Petersen, Eric J. Vargas Valls, Ryan Law, Samuel Han, Vinay Chandrasekhara
Background: Self-expanding metal stents (SEMS) are recommended for the endoscopic palliation of distal malignant biliary obstruction (DMBO). Placement of SEMS during endoscopic retrograde cholangiopancreatography (ERCP) has been associated with an increased risk of post-ERCP pancreatitis (PEP). Objectives: The aim of this study is to evaluate rates of PEP in patients who underwent SEMS placement for pancreatic versus non-pancreatic malignancy. Design: Retrospective Cohort Study. Methods: Patients who underwent SEMS placement for DMBO between June 2017 and May 2021 were identified retrospectively from a procedural billing database. PEP incidence was compared between pancreatic and non-pancreatic DMBO groups and multivariate logistic regression was performed to identify risk factors for PEP. Results: A total of 488 individuals were identified, with 395 (80.9%) cases of DMBO due to pancreatic and 93 (19.1%) due to non-pancreatic malignancy. Stent types included 124 (25.4%) fully covered (FCSEMS) and 364 (74.6%) uncovered metal stents (UCSEMS). The overall rate of PEP in the cohort was 6.3% with no significant difference between pancreatic and non-pancreatic etiologies (6.1% vs 7.5%, p = 0.606). When adjusted for age <50 years old, female sex, and pancreatic stent placement, a non-pancreatic malignancy was not associated with an increased risk of PEP (OR 0.83, 95% CI 0.36–2.15). Conclusion: No statistically significant difference in PEP rates was seen after biliary sphincterotomy and SEMS placement for palliation of DMBO in patients with pancreatic versus non-pancreatic malignancies.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
AbiMansour, J., Petersen, B., Valls, E., et al. (2026). Post-ERCP pancreatitis after self-expanding metal stent placement in patients with pancreatic versus non-pancreatic malignant biliary obstruction. Therapeutic Advances in Gastrointestinal Endoscopy. https://doi.org/10.1177/26317745261458987